Carcinomatosis

9 registered clinical trials studyying Carcinomatosis — 2 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Dual Administration Of Intraperitoneal And Intravenous TROP2-Directed CAR-NK With TGF-Beta Receptor 2 (TGFBR2) NCT07411599	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Withdrawn	Study of VG2025 Delivered Intraperitoneally in Patients With Advanced Solid Tumors With Carcinomatosis NCT06365918	M.D. Anderson Cancer Center	Phase 1
Recruiting	A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Pos NCT05977998	M.D. Anderson Cancer Center	Phase 2
Completed	Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic I NCT05083338	M.D. Anderson Cancer Center	—
Completed	Perioperative Coagulopathy in Patients Undergoing Cytoreductive Surgery and HIPEC Intraperitoneal Chemotherapy NCT03956836	Hospitales Universitarios Virgen del Rocío	—
Active Not Recruiting	Adavosertib Before Surgery in Treating Patients With Advanced High Grade Ovarian, Fallopian Tube, or Primary P NCT02659241	M.D. Anderson Cancer Center	EARLY_Phase 1
Unknown	Immunologic Profile of Peritoneal Cancer NCT03230240	MercyOne Des Moines Medical Center	—
Completed	B-type Natriuretic Peptide in the Diagnosis of Heart Failure Related Ascites NCT01150916	University of Sao Paulo	N/A
Completed	Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal Carcinomatosis NCT00332696	Novartis Pharmaceuticals	Phase 2